[HTML] nih.gov

[HTML][HTML] Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice

SE Perez, M Nadeem, KR Sadleir, J Matras… - … journal of physiology …, 2012 - ncbi.nlm.nih.gov
A double blind, placebo-controlled phase II study revealed that the antihistamine,
Dimebon®(dimebolin, latrepirdine) improved cognition in Alzheimer disease (AD) patients …
被引用次数：34 相关文章
[PDF] academia.edu

[PDF][PDF] Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice

SE Perez, M Nadeem, KR Sadleir, J Matras… - Int J Physiol …, 2012 - academia.edu
A double blind, placebo-controlled phase II study revealed that the antihistamine,
Dimebon®(dimebolin, latrepirdine) improved cognition in Alzheimer disease (AD) patients …
[PDF] e-century.us

[PDF][PDF] Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice

SE Perez, M Nadeem, KR Sadleir, J Matras… - Int J Physiol …, 2012 - e-century.us
A double blind, placebo-controlled phase II study revealed that the antihistamine,
Dimebon®(dimebolin, latrepirdine) improved cognition in Alzheimer disease (AD) patients …

Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice

SE Perez, M Nadeem, KR Sadleir… - International …, 2012 - scholars.northwestern.edu
A double blind, placebo-controlled phase II study revealed that the antihistamine,
Dimebon®(dimebolin, latrepirdine) improved cognition in Alzheimer disease (AD) patients …

Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice

SE Perez, M Nadeem, KR Sadleir… - International …, 2012 - pubmed.ncbi.nlm.nih.gov
A double blind, placebo-controlled phase II study revealed that the antihistamine,
Dimebon®(dimebolin, latrepirdine) improved cognition in Alzheimer disease (AD) patients …

Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice.

SE Perez, M Nadeem, KR Sadleir, J Matras… - … Journal of Physiology …, 2012 - europepmc.org
A double blind, placebo-controlled phase II study revealed that the antihistamine,
Dimebon®(dimebolin, latrepirdine) improved cognition in Alzheimer disease (AD) patients …
[PDF] researchgate.net

[PDF][PDF] Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice

SE Perez, M Nadeem, KR Sadleir… - Int J Physiol …, 2012 - researchgate.net
A double blind, placebo-controlled phase II study revealed that the antihistamine,
Dimebon®(dimebolin, latrepirdine) improved cognition in Alzheimer disease (AD) patients …

Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice

SE Perez, M Nadeem, KR Sadleir… - International …, 2012 - scholar.barrowneuro.org
A double blind, placebo-controlled phase II study revealed that the antihistamine,
Dimebon®(dimebolin, latrepirdine) improved cognition in Alzheimer disease (AD) patients …
[PDF] researchgate.net

[PDF][PDF] Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice

SE Perez, M Nadeem, KR Sadleir… - Int J Physiol …, 2012 - researchgate.net
A double blind, placebo-controlled phase II study revealed that the antihistamine,
Dimebon®(dimebolin, latrepirdine) improved cognition in Alzheimer disease (AD) patients …
[PDF] academia.edu

[PDF][PDF] Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice

SE Perez, M Nadeem, KR Sadleir, J Matras… - Int J Physiol …, 2012 - academia.edu
A double blind, placebo-controlled phase II study revealed that the antihistamine,
Dimebon®(dimebolin, latrepirdine) improved cognition in Alzheimer disease (AD) patients …